Neogenomics Inc.’s filing revealed that its Director TETRAULT LYNN A. unloaded Company’s shares for reported $97579.0 on Mar 04 ’24. In the deal valued at $15.97 per share,6,112 shares were sold. As a result of this transaction, TETRAULT LYNN A. now holds 50,062 shares worth roughly $0.74 million.
Then, Olivo Alicia C sold 2,587 shares, generating $38,713 in total proceeds. Upon selling the shares at $14.96, the General Counsel now owns 34,866 shares.
Before that, Olivo Alicia C sold 2,669 shares. Neogenomics Inc. shares valued at $49,083 were divested by the General Counsel at a price of $18.39 per share. As a result of the transaction, Olivo Alicia C now holds 37,140 shares, worth roughly $0.55 million.
BTIG Research reiterated its Neogenomics Inc. [NEO] rating to a Buy in a research note published on December 29, 2023; the price target was $21. A number of analysts have revised their coverage, including Stephens’s analysts, who increased its forecast for the stock in late August from “an Equal-weight” to “an Overweight”. Raymond James also remained covering NEO and has decreased its forecast on May 16, 2023 with a “Mkt perform” recommendation from previously “an Outperform” rating. BTIG Research revised its rating on May 09, 2023. It rated NEO as “a Buy” which previously was an “a Neutral”.
Price Performance Review of NEO
On Monday, Neogenomics Inc. [NASDAQ:NEO] saw its stock fall -0.47% to $14.85. Over the last five days, the stock has lost -3.51%. Neogenomics Inc. shares have fallen nearly -8.22% since the year began. Nevertheless, the stocks have risen 0.27% over the past one year. While a 52-week high of $21.22 was reached on 02/23/24, a 52-week low of $11.03 was recorded on 02/08/24. SMA at 50 days reached $15.25, while 200 days put it at $15.57. A total of 0.51 million shares were traded, compared to the trading of 0.62 million shares in the previous session.
Levels Of Support And Resistance For NEO Stock
The 24-hour chart illustrates a support level at 14.57, which if violated will result in even more drops to 14.30. On the upside, there is a resistance level at 15.16. A further resistance level may holdings at 15.48. The Relative Strength Index (RSI) on the 14-day chart is 45.15, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.25, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 71.62%. Stochastics %K at 32.44% indicates the stock is a holding.
How much short interest is there in Neogenomics Inc.?
A steep rise in short interest was recorded in Neogenomics Inc. stocks on Mar 15, 2024, dropping by -0.16 million shares to a total of 7.29 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 7.45 million shares. There was a decline of -2.19%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 8.06% of the overall stock float, the days-to-cover ratio (short ratio) fell to 6.39.
